Full Press Release Details
Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX s property and
Introduced 30/9/2001.
| Name of Entity: | PRIMA BIOMED LIMITED (ASX:PRR) | |
| ACN: | 90 009 237 889 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes
of section 205G of the Corporations Act.
| Name of Director: | Mr Matthew Lehman | |
| Date of Last Notice: | 10 October 2013 |
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a director should be
disclosed in this part.
| Direct or indirect interest | Direct | |||||||||
| Nature of indirect interest | N/A | |||||||||
| (including registered holder) | ||||||||||
| Note: Provide details of the circumstances giving rise to the relevant interest. | ||||||||||
| Date of change | 21 November 2013 | |||||||||
| No. of securities held prior to change | 1) Ordinary Fully Paid Shares | |||||||||
| Shares | Options | |||||||||
| Direct | 1,617,763 | 2,104,441 | ||||||||
| Indirect | ||||||||||
| Total | 1,617,763 | 2,104,441 | ||||||||
| 2) American Depositary Receipts (ADR) | ||||||||||
| Shares | Options | |||||||||
| Direct | 17,900 | |||||||||
| Indirect | ||||||||||
| Total | 17,900 |
Change of Director s Interest Notice
| Class | 2) American Depositary Receipts (ADR) traded on the NASDAQ 1 ADR = 30 ordinary fully paid shares | |||||||||
| Number acquired | 1) Ordinary Fully Paid Shares | |||||||||
| Shares | Options | |||||||||
| Direct | ||||||||||
| Indirect | ||||||||||
| Total | ||||||||||
| 2) American Depositary Receipts (ADR) | ||||||||||
| Shares | Options | |||||||||
| Direct | 14,806 | |||||||||
| Indirect | ||||||||||
| Total | 14,806 | |||||||||
| Number disposed | ||||||||||
| Shares | Options | |||||||||
| Direct | ||||||||||
| Indirect | ||||||||||
| Total | ||||||||||
| Value/Consideration | US$ 15,958.19 | |||||||||
| Note: If consideration is non-cash, provide details and estimated valuation | ||||||||||
| No. of securities held after change | 1) Ordinary Fully Paid Shares | |||||||||
| Shares | Options | |||||||||
| Direct | 1,617,763 | 2,104,441 | ||||||||
| Indirect | ||||||||||
| Total | 1,617,763 | 2,104,441 | ||||||||
| 2) American Depositary Receipts (ADR) | ||||||||||
| Shares | Options | |||||||||
| Direct | 32,706 | |||||||||
| Indirect | ||||||||||
| Total | 32,706 |
Change of Director s Interest Notice
Part 2 - Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be
disclosed in this part.
| Detail of contract | N/A | |
| Nature of interest | ||
| Name of registered holder | ||
| (if issued securities) | ||
| Date of change | ||
| No. and class of securities to which interest related prior to change | ||
| Note: Details are only required for a contract in relation to which the interest has changed | ||
| Interest acquired | ||
| Interest disposed | ||
| Value/Consideration | ||
| Note: If consideration is non-cash, provide details and an estimated valuation | ||
| Interest after change |
Part 3 - +Closed Period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No | |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | ||
| If prior written clearance was provided on what date was this provided? |